AstraZeneca PLC (AZN.L)
| Previous close | 12,060.00 |
| Open | 12,116.00 |
| Bid | 12,182.00 x 0 |
| Ask | 12,186.00 x 0 |
| Day's range | 12,108.00 - 12,332.00 |
| 52-week range | 9,461.00 - 12,704.00 |
| Volume | |
| Avg. volume | 1,896,525 |
| Market cap | 188.823B |
| Beta (5Y monthly) | 0.15 |
| PE ratio (TTM) | 38.06 |
| EPS (TTM) | 3.20 |
| Earnings date | 25 Jul 2024 |
| Forward dividend & yield | 2.34 (1.92%) |
| Ex-dividend date | 08 Aug 2024 |
| 1y target est | 133.44 |
Simply Wall St.AstraZeneca Second Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags
AstraZeneca ( LON:AZN ) Second Quarter 2024 Results Key Financial Results Revenue: US$12.9b (up 13% from 2Q 2023). Net...
ZacksPharma Stock Roundup: AZN, SNY, ABBV Q2 Earnings, PFE & MRK's Positive Pipeline News
AstraZeneca (AZN), Sanofi (SNY) and AbbVie (ABBV) announce second-quarter results. Merck (MRK) and Pfizer's (PFE) phase III studies achieve primary goals.
Simply Wall St.Top 3 UK Stocks Estimated To Be Undervalued In July 2024
The United Kingdom's stock market has recently experienced declines, influenced by disappointing trade data from China and its broader economic challenges. Amidst these market conditions, identifying undervalued stocks can offer investors potential opportunities for value in a landscape marked by global uncertainties. In this environment, a good stock may be characterized by robust fundamentals such as strong balance sheets and consistent earnings, which provide resilience against ongoing...
